| $31M2018-08-14 |  Magnolia Neurosciences | ARCH Venture Partners, Alexandria Venture Investments, AbbVie, Eli Lilly and Company, Partnership Fund for New York City, Pfizer Ventures |
| $48M2016-01-06 |  Petra Pharma | ARCH Venture Partners, Alexandria Venture Investments, AbbVie, Eli Lilly and Company, Partnership Fund for New York City, Pfizer Ventures |
| $90MUnknown date |  Syndeio Biosciences | ARCH Venture Partners, Catalio Capital Management, AbbVie, Eli Lilly and Company, Palo Santo, Tenmile |
Bryan FaustScientist - Biophysics